HAMPTON, N.H.--(BUSINESS WIRE)--Jan. 19, 2006--Fisher Scientific
International Inc. (NYSE: FSH) announced that it will present at the
Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device
conference on Feb. 9 at 11:40 a.m. Eastern Standard Time (EST) at the
Grand Hyatt Hotel in New York City. Access to the webcast of the
presentation and the presentation slides will be available on the
company's Web site at www.fisherscientific.com on the day of the
conference and will be archived until March 1.
Fisher Scientific: A World Leader in Serving Science
Fisher Scientific International Inc. (NYSE: FSH) is a leading
provider of products and services to the scientific community. Fisher
facilitates discovery by supplying researchers and clinicians in labs
around the world with the tools they need. We serve pharmaceutical and
biotech companies; colleges and universities; medical-research
institutions; hospitals; reference, quality-control, process-control
and R&D labs in various industries; as well as government agencies.
From biochemicals, cell-culture media and proprietary RNAi technology
to rapid-diagnostic tests, safety products and other consumable
supplies, Fisher provides more than 600,000 products and services.
This broad offering, combined with Fisher's globally integrated supply
chain and unmatched sales and marketing presence, helps make our
350,000 customers more efficient and effective at what they do.
Founded in 1902, Fisher Scientific is a FORTUNE 500 company and is
a component of the S&P 500 Index. Fisher Scientific is a company
committed to high standards and delivering on our promises -- to
customers, shareholders and employees alike. Additional information
about Fisher is available on the company's Web site at
www.fisherscientific.com.
CONTACT: Fisher Scientific International Inc.
Media Contact:
Gia L. Oei, 603-929-2489
E-mail: gia.oei@fishersci.com
or
Investor Contact:
Chet Mehta, 603-929-2260
E-mail: chet.mehta@fishersci.com
SOURCE: Fisher Scientific International Inc.
